Kalaba, Ana

Link to this page

Authority KeyName Variants
83e9d004-591b-4159-9bcb-cf3a882c8d63
  • Kalaba, Ana (2)
Projects

Author's Bibliography

Drug-Related Problems Prior to Hospitalization on Internal Medicine Wards

Draganov, Ivana; Drndarević, Aneta; Kovačević, Milena; Miljković, Branislava; Vuksanović, Miljanka; Janković, Aleksandar; Kalaba, Ana; Vezmar-Kovačević, Sandra

(Polish Pharmaceutical Society, 2024)

TY  - JOUR
AU  - Draganov, Ivana
AU  - Drndarević, Aneta
AU  - Kovačević, Milena
AU  - Miljković, Branislava
AU  - Vuksanović, Miljanka
AU  - Janković, Aleksandar
AU  - Kalaba, Ana
AU  - Vezmar-Kovačević, Sandra
PY  - 2024
UR  - https://farfar.pharmacy.bg.ac.rs/handle/123456789/5604
AB  - Drug-related hospitalizations pose a significant burden to the health-care system. The aim
was to investigate the prevalence of drug-related problems (DRPs) and their association with hospital
admissions in five internal medicine wards. The study included patients admitted to the nephrology,
cardiology, gastroenterology, endocrinology, and geriatric wards. The Pharmaceutical Care Network
Europe classification V9.1 was used for identifying DRPs. In total, 535 patients participated in the study.
We identified 954 DRPs (range 1-7) in 80.7% of patients. Most DRPs were identified on the endocrinology,
cardiology, and geriatric wards, and they were associated with the efficacy of treatment (71.4%), adverse
drug events (10.2%), and unnecessary drug treatment (18.4%). DRPs were associated with the cause of
hospitalization in 74.4% of patients on the nephrology ward, 60.1% and 60.6% of patients on the cardiology
and endocrinology wards, respectively, whereas this number was lower on the geriatric and gastroenterology
wards (26.9% and 8.9%, respectively). Suboptimal drug treatment due to medication omissions was often
associated with the potential cause of hospital admission. Focusing on patients with specific diseases and
DRPs, rather than reducing the number of medications in primary care, may be potentially rational in an
attempt to reduce drug-related hospitalizations.
PB  - Polish Pharmaceutical Society
T2  - Acta Poloniae Pharmaceutica - Drug Research
T1  - Drug-Related Problems Prior to Hospitalization on Internal Medicine Wards
VL  - 81
IS  - 1
SP  - 145
EP  - 154
DO  - 10.32383/appdr/182840
ER  - 
@article{
author = "Draganov, Ivana and Drndarević, Aneta and Kovačević, Milena and Miljković, Branislava and Vuksanović, Miljanka and Janković, Aleksandar and Kalaba, Ana and Vezmar-Kovačević, Sandra",
year = "2024",
abstract = "Drug-related hospitalizations pose a significant burden to the health-care system. The aim
was to investigate the prevalence of drug-related problems (DRPs) and their association with hospital
admissions in five internal medicine wards. The study included patients admitted to the nephrology,
cardiology, gastroenterology, endocrinology, and geriatric wards. The Pharmaceutical Care Network
Europe classification V9.1 was used for identifying DRPs. In total, 535 patients participated in the study.
We identified 954 DRPs (range 1-7) in 80.7% of patients. Most DRPs were identified on the endocrinology,
cardiology, and geriatric wards, and they were associated with the efficacy of treatment (71.4%), adverse
drug events (10.2%), and unnecessary drug treatment (18.4%). DRPs were associated with the cause of
hospitalization in 74.4% of patients on the nephrology ward, 60.1% and 60.6% of patients on the cardiology
and endocrinology wards, respectively, whereas this number was lower on the geriatric and gastroenterology
wards (26.9% and 8.9%, respectively). Suboptimal drug treatment due to medication omissions was often
associated with the potential cause of hospital admission. Focusing on patients with specific diseases and
DRPs, rather than reducing the number of medications in primary care, may be potentially rational in an
attempt to reduce drug-related hospitalizations.",
publisher = "Polish Pharmaceutical Society",
journal = "Acta Poloniae Pharmaceutica - Drug Research",
title = "Drug-Related Problems Prior to Hospitalization on Internal Medicine Wards",
volume = "81",
number = "1",
pages = "145-154",
doi = "10.32383/appdr/182840"
}
Draganov, I., Drndarević, A., Kovačević, M., Miljković, B., Vuksanović, M., Janković, A., Kalaba, A.,& Vezmar-Kovačević, S.. (2024). Drug-Related Problems Prior to Hospitalization on Internal Medicine Wards. in Acta Poloniae Pharmaceutica - Drug Research
Polish Pharmaceutical Society., 81(1), 145-154.
https://doi.org/10.32383/appdr/182840
Draganov I, Drndarević A, Kovačević M, Miljković B, Vuksanović M, Janković A, Kalaba A, Vezmar-Kovačević S. Drug-Related Problems Prior to Hospitalization on Internal Medicine Wards. in Acta Poloniae Pharmaceutica - Drug Research. 2024;81(1):145-154.
doi:10.32383/appdr/182840 .
Draganov, Ivana, Drndarević, Aneta, Kovačević, Milena, Miljković, Branislava, Vuksanović, Miljanka, Janković, Aleksandar, Kalaba, Ana, Vezmar-Kovačević, Sandra, "Drug-Related Problems Prior to Hospitalization on Internal Medicine Wards" in Acta Poloniae Pharmaceutica - Drug Research, 81, no. 1 (2024):145-154,
https://doi.org/10.32383/appdr/182840 . .

Pharmacokinetics and clinical evaluation of vedolizumab based on real-life routine monitoring data in IBD patients

Marković, Srđan; Kralj, Đorđe; Odanović, Olga; Homšek, Ana; Kalaba, Ana; Svorcan, Petar; Vučićević, Katarina

(Oxford Academic Press, 2023)

TY  - CONF
AU  - Marković, Srđan
AU  - Kralj, Đorđe
AU  - Odanović, Olga
AU  - Homšek, Ana
AU  - Kalaba, Ana
AU  - Svorcan, Petar
AU  - Vučićević, Katarina
PY  - 2023
UR  - https://farfar.pharmacy.bg.ac.rs/handle/123456789/4828
PB  - Oxford Academic Press
C3  - Journal of Crohn's and Colitis
T1  - Pharmacokinetics and clinical evaluation of vedolizumab based on real-life routine monitoring data in IBD patients
VL  - 17
IS  - Supplement 1
SP  - i925
EP  - i925
DO  - 10.1093/ecco-jcc/jjac190.0922
ER  - 
@conference{
author = "Marković, Srđan and Kralj, Đorđe and Odanović, Olga and Homšek, Ana and Kalaba, Ana and Svorcan, Petar and Vučićević, Katarina",
year = "2023",
publisher = "Oxford Academic Press",
journal = "Journal of Crohn's and Colitis",
title = "Pharmacokinetics and clinical evaluation of vedolizumab based on real-life routine monitoring data in IBD patients",
volume = "17",
number = "Supplement 1",
pages = "i925-i925",
doi = "10.1093/ecco-jcc/jjac190.0922"
}
Marković, S., Kralj, Đ., Odanović, O., Homšek, A., Kalaba, A., Svorcan, P.,& Vučićević, K.. (2023). Pharmacokinetics and clinical evaluation of vedolizumab based on real-life routine monitoring data in IBD patients. in Journal of Crohn's and Colitis
Oxford Academic Press., 17(Supplement 1), i925-i925.
https://doi.org/10.1093/ecco-jcc/jjac190.0922
Marković S, Kralj Đ, Odanović O, Homšek A, Kalaba A, Svorcan P, Vučićević K. Pharmacokinetics and clinical evaluation of vedolizumab based on real-life routine monitoring data in IBD patients. in Journal of Crohn's and Colitis. 2023;17(Supplement 1):i925-i925.
doi:10.1093/ecco-jcc/jjac190.0922 .
Marković, Srđan, Kralj, Đorđe, Odanović, Olga, Homšek, Ana, Kalaba, Ana, Svorcan, Petar, Vučićević, Katarina, "Pharmacokinetics and clinical evaluation of vedolizumab based on real-life routine monitoring data in IBD patients" in Journal of Crohn's and Colitis, 17, no. Supplement 1 (2023):i925-i925,
https://doi.org/10.1093/ecco-jcc/jjac190.0922 . .